Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

Corrections & amendments Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B Correction to: Nature Immunology https://doi.org/10.1038/s41590-022-01290-3, published online 24 August 2022. https://doi.org/10.1038/s41590-024-01984-w Published online: xx xx xxxx Check for updates Martina Musella, Andrea Guarracino , Nicoletta Manduca, Claudia Galassi, Eliana Ruggiero, Alessia Potenza, Ester Maccafeo, Gwenola Manic , Luca Mattiello, Sara Soliman Abdel Rehim, Michele Signore, Marco Pietrosanto, Manuela Helmer-Citterich, Matteo Pallocca, Maurizio Fanciulli, Tiziana Bruno, Francesca De Nicola, Giacomo Corleone, Anna Di Benedetto, Cristiana Ercolani, Edoardo Pescarmona, Laura Pizzuti, Francesco Guidi, Francesca Sperati, Sara Vitale, Daniele Macchia, Massimo Spada, Giovanna Schiavoni , Fabrizio Mattei, Adele De Ninno, Luca Businaro, Valeria Lucarini, Laura Bracci, Eleonora Aricò, Giovanna Ziccheddu, Francesco Facchiano, Stefania Rossi, Massimo Sanchez , Alessandra Boe , Mauro Biffoni, Ruggero De Maria , Ilio Vitale & Antonella Sistigu In the version of this article initially published, due to an error during figure assembly, the image shown in the top-right WT mice, PAR cells, panel of Fig. 4d was a duplicate of the lower-left image in the CD4–/–CD8–/– mice, CD44L cells, panel. The figure has been updated in the HTML and PDF versions of the article. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/ licenses/by/4.0/. © The Author(s) 2024 nature immunology  (...truncated)